Results 201 to 210 of about 83,984 (282)

Impact of preoperative triglyceride levels on hepatic encephalopathy development in TIPS patients: a retrospective cohort study. [PDF]

BMC Gastroenterol
Cai F, Yu J, Qin L.
europepmc   +1 more source

Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 8, Page 1109-1118, April 2026.
In a national cohort of newly decompensated Veterans with cirrhosis, SBP and recurrences are linked with higher death and need for liver transplant. SBP prophylaxis, whether primary or secondary, worsens resistance and interacts with mortality but not liver transplant.
Scott Silvey, Nilang Patel, Jacqueline G. O'Leary, Timothy Morgan, John D. Markley, Sofia S. Jakab, Heather Patton, Shari Rogal, Jasmohan S. Bajaj   +8 more
wiley   +1 more source

Animal naming test at discharge is associated with hepatic encephalopathy after elective TIPS. [PDF]

JHEP Rep
Jorus M, Sultanik P, Bouzbib C, Mouri S, Kheloufi L, Gasperment M, Weiss N, Roux C, Thabut D, Rudler M.   +9 more
europepmc   +1 more source

Transplantation and other aspects of surgery of the liver [PDF]

, 1984
Iwatsuki, S, Shaw, BW, Starzl, TE, Van Thiel, DH   +3 more
core  

Barriers to Medical Care Are Frequently Reported by Patients With Cirrhosis

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 8, Page 1162-1168, April 2026.
In a telephone‐based survey study among > 1000 patients with cirrhosis, the most frequent barriers to care included time to travel to clinic, long wait times for appointments, and difficulty scheduling visits. Several barriers to care significantly differed by study site but were generally consistent across racial and ethnic subgroups.
William Chai, Nicole E. Rich, Yan Liu, Juana Campos, Lisa Quirk, Jennifer R. Kramer, Jahna Anyanwu, Amanda Gibbons, Aaron Loewy, Dalal Youssef, Riya Malhorta, Hadley McGhee, Meena Tadros, Fasiha Kanwal, Amit G. Singal   +14 more
wiley   +1 more source

Comparison of probiotics to lactulose for minimal hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. [PDF]

Front Med (Lausanne)
He Q, Chen Z, Deng Y, Mao C, Fan Y.
europepmc   +1 more source

Encephalopathy or hepatic encephalopathy?

Journal of Hepatology, 2012
MONTAGNESE, SARA, MERKEL, CARLO, AMODIO, PIERO   +2 more
openaire   +3 more sources

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.
In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.
Marco Sanduzzi‐Zamparelli, Ana Matilla, José Luis Lledo, Sergio Muñoz‐Martínez, María Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Mínguez, Neus Llarch, Laura Márquez, Antonio Guerrero, Gemma Iserte, Andrés Castaño‐García, Laura Carrión, Marta Fortuny, Jordi Rimola, Ángeles García‐Criado, Gema Domenech, Ferran Torres, José Rios‐Guillermo, Loreto Boix, Esther Samper, Àngels Kateb, Jordi Bruix, Maria Reig   +24 more
wiley   +1 more source

Role of cerebral blood flow changes in post-transjugular intrahepatic portosystemic shunts hepatic encephalopathy. [PDF]

World J Radiol
Zhuang WL, Xu SW, Fang J, Zhang ZQ, Zhang SA, Wang JL, Zheng JL, Wang XY, Li DL.   +8 more
europepmc   +1 more source

Portal-systemic shunting for metabolic disease [PDF]

, 1985
Iwatsuki, S, Porter, KA, Starzl, TE
core